trending Market Intelligence /marketintelligence/en/news-insights/trending/tCMI_hvGGudrIceIPCxOjw2 content esgSubNav
In This List

Biocept to undertake $2.2M private placement

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Biocept to undertake $2.2M private placement

Ally Bridge LB Healthcare Master Fund Ltd. is investing some $2.2 million in Biocept Inc. by acquiring 1,466,667 shares of the company at $1.50 apiece.

The shares come bundled with five-year warrants to buy up to an additional 1,434,639 stocks, also at $1.50 apiece.

The offering is expected to close Aug. 10.

Biocept and Ally Bridge's Chinese affiliate are also in discussions to evaluate potential strategic opportunities to leverage the company's liquid biopsy platform in China.

The company was granted patents covering its proprietary technology in China.